Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin to enhance neurorecovery after stroke
2011-000123-33Phase 4Terminated
- Sponsor
- King's College Hospital
- Start
- Apr 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of epoetin alfa in stroke, sponsored by King's College Hospital. Primary endpoint: Fugl-Meyer scale score at 90 days. Started Apr 2011; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
stroke
Beyond the preview
Go deeper on 2011-000123-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000123-33.